Literature DB >> 12091320

PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum.

Silvia Marino1, Paul Krimpenfort, Carly Leung, Hetty A G M van der Korput, Jan Trapman, Isabelle Camenisch, Anton Berns, Sebastian Brandner.   

Abstract

PTEN is a tumour suppressor gene involved in cell cycle control, apoptosis and mediation of adhesion and migration signalling. Germline mutations of PTEN in humans are associated with familial tumour syndromes, among them Cowden disease. Glioblastomas, highly malignant glial tumours of the central nervous system frequently show loss of PTEN. Recent reports have outlined some aspects of PTEN function in central nervous system development. Using a conditional gene disruption approach, we inactivated Pten in mice early during embryogenesis locally in a region specific fashion and later during postnatal development in a cell-specific manner, to study the role of PTEN in differentiation, migration and neoplastic transformation. We show that PTEN is required for the realisation of normal cerebellar architecture, for regulation of cell and organ size, and for proper neuronal and glial migration. However, PTEN is not required for cell differentiation and lack of PTEN is not sufficient to induce neoplastic transformation of neuronal or glial cells

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091320     DOI: 10.1242/dev.129.14.3513

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  79 in total

1.  Inhibition of neuronal phenotype by PTEN in PC12 cells.

Authors:  Sergei Musatov; Jill Roberts; Andrew I Brooks; John Pena; Simone Betchen; Donald W Pfaff; Michael G Kaplitt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

Review 2.  Mouse models of inherited cancer syndromes.

Authors:  Sohail Jahid; Steven Lipkin
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

3.  Nonautonomous regulation of neuronal migration by insulin signaling, DAF-16/FOXO, and PAK-1.

Authors:  Lisa M Kennedy; Steven C D L Pham; Alla Grishok
Journal:  Cell Rep       Date:  2013-08-29       Impact factor: 9.423

4.  Nuclear PTEN deficiency causes microcephaly with decreased neuronal soma size and increased seizure susceptibility.

Authors:  Atsushi Igarashi; Kie Itoh; Tatsuya Yamada; Yoshihiro Adachi; Takashi Kato; Daisuke Murata; Hiromi Sesaki; Miho Iijima
Journal:  J Biol Chem       Date:  2018-05-07       Impact factor: 5.157

5.  Presenilins regulate the cellular level of the tumor suppressor PTEN.

Authors:  Han Zhang; Runzhong Liu; Ruishan Wang; Shuigen Hong; Huaxi Xu; Yun-wu Zhang
Journal:  Neurobiol Aging       Date:  2007-01-12       Impact factor: 4.673

6.  PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry.

Authors:  Matthias Groszer; Rebecca Erickson; Deirdre D Scripture-Adams; Joseph D Dougherty; Janel Le Belle; Jerome A Zack; Daniel H Geschwind; Xin Liu; Harley I Kornblum; Hong Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

7.  Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis.

Authors:  Caroline Gregorian; Jonathan Nakashima; Janel Le Belle; John Ohab; Rachel Kim; Annie Liu; Kate Barzan Smith; Matthias Groszer; A Denise Garcia; Michael V Sofroniew; S Thomas Carmichael; Harley I Kornblum; Xin Liu; Hong Wu
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

8.  Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma.

Authors:  Marta Moral; Carmen Segrelles; M Fernanda Lara; Ana Belén Martínez-Cruz; Corina Lorz; Mirentxu Santos; Ramón García-Escudero; Jerry Lu; Kaoru Kiguchi; Agueda Buitrago; Clotilde Costa; Cristina Saiz; Jose L Rodriguez-Peralto; Francisco J Martinez-Tello; Maria Rodriguez-Pinilla; Montserrat Sanchez-Cespedes; Marina Garín; Teresa Grande; Ana Bravo; John DiGiovanni; Jesús M Paramio
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

9.  Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains.

Authors:  Nader Chalhoub; Guo Zhu; Xiaoyan Zhu; Suzanne J Baker
Journal:  Genes Dev       Date:  2009-07-15       Impact factor: 11.361

10.  Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes.

Authors:  David K Finlay; Linda V Sinclair; Carmen Feijoo; Caryll M Waugh; Thijs J Hagenbeek; Hergen Spits; Doreen A Cantrell
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.